These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9865862

  • 21. Different agonist binding properties of M1 and M2 muscarinic receptors in calf brain cortex membranes.
    Vanderheyden P, Ebinger G, Vauquelin G.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4119-24. PubMed ID: 3689439
    [Abstract] [Full Text] [Related]

  • 22. Muscarinic cholinoceptor activation modulates DNA synthesis and CD40 expression in fibroblast cells.
    Casanova M, Furlán C, Sterin-Borda L, Borda ES.
    Auton Autacoid Pharmacol; 2006 Jul 01; 26(3):293-301. PubMed ID: 16879495
    [Abstract] [Full Text] [Related]

  • 23. Agonist activation of transfected human M1 muscarinic acetylcholine receptors in CHO cells results in down-regulation of both the receptor and the alpha subunit of the G-protein Gq.
    Mullaney I, Dodd MW, Buckley N, Milligan G.
    Biochem J; 1993 Jan 01; 289 ( Pt 1)(Pt 1):125-31. PubMed ID: 8424750
    [Abstract] [Full Text] [Related]

  • 24. Cloning of the rat M3, M4 and M5 muscarinic acetylcholine receptor genes by the polymerase chain reaction (PCR) and the pharmacological characterization of the expressed genes.
    Kashihara K, Varga EV, Waite SL, Roeske WR, Yamamura HI.
    Life Sci; 1992 Jan 01; 51(12):955-71. PubMed ID: 1325587
    [Abstract] [Full Text] [Related]

  • 25. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul 01; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 26. Agonist-induced down-regulation of the m4 muscarinic acetylcholine receptor occurs without changes in receptor mRNA steady-state levels.
    Lenz W, Petrusch C, Jakobs KH, van Koppen CJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Nov 01; 350(5):507-13. PubMed ID: 7870190
    [Abstract] [Full Text] [Related]

  • 27. Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors.
    Richards MH.
    Br J Pharmacol; 1990 Apr 01; 99(4):753-61. PubMed ID: 1694463
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.
    Watson M, Yamamura HI, Roeske WR.
    Life Sci; 1983 Jun 27; 32(26):3001-11. PubMed ID: 6688111
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Differential regulation by agonist and phorbol ester of cloned m1 and m2 muscarinic acetylcholine receptors in mouse Y1 adrenal cells and in Y1 cells deficient in cAMP-dependent protein kinase.
    Scherer NM, Nathanson NM.
    Biochemistry; 1990 Sep 11; 29(36):8475-83. PubMed ID: 2174702
    [Abstract] [Full Text] [Related]

  • 33. Chimeric M1/M2 muscarinic receptors: correlation of ligand selectivity and functional coupling with structural modifications.
    Lai J, Nunan L, Waite SL, Ma SW, Bloom JW, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1992 Jul 11; 262(1):173-80. PubMed ID: 1625198
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M, Yamamura HI, Roeske WR.
    J Pharmacol Exp Ther; 1986 May 11; 237(2):411-8. PubMed ID: 3754580
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.